10X Genomics, Inc. (TXG)
77.00
-3.66
(-4.54%)
USD |
NASDAQ |
Oct 07, 10:33
10X Genomics Net Income (Quarterly) : -17.93M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.93M |
| March 31, 2026 | -13.47M |
| December 31, 2025 | -16.25M |
| September 30, 2025 | -27.47M |
| June 30, 2025 | 34.54M |
| March 31, 2025 | -34.36M |
| December 31, 2024 | -49.03M |
| September 30, 2024 | -35.75M |
| June 30, 2024 | -37.90M |
| March 31, 2024 | -59.95M |
| December 31, 2023 | -48.95M |
| September 30, 2023 | -92.99M |
| June 30, 2023 | -62.41M |
| March 31, 2023 | -50.75M |
| December 31, 2022 | -17.22M |
| September 30, 2022 | -41.91M |
| June 30, 2022 | -64.46M |
| March 31, 2022 | -42.41M |
| December 31, 2021 | -18.45M |
| Date | Value |
|---|---|
| September 30, 2021 | -17.17M |
| June 30, 2021 | -11.05M |
| March 31, 2021 | -11.55M |
| December 31, 2020 | -415.57M |
| September 30, 2020 | -65.85M |
| June 30, 2020 | -40.17M |
| March 31, 2020 | -21.14M |
| December 31, 2019 | -7.134M |
| September 30, 2019 | -9.603M |
| June 30, 2019 | -10.88M |
| March 31, 2019 | -3.636M |
| December 31, 2018 | -75.52M |
| September 30, 2018 | -15.34M |
| June 30, 2018 | -5.923M |
| March 31, 2018 | -15.69M |
| December 31, 2017 | -4.183M |
| September 30, 2017 | -4.541M |
| June 30, 2017 | -3.753M |
| March 31, 2017 | -6.285M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Twist Bioscience Corp. | -35.05M |
| Tempus AI, Inc. | 5.642M |
| Personalis, Inc. | -31.68M |
| Alamar Biosciences, Inc. (California) | -13.20M |
| Beam Therapeutics, Inc. | -122.68M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 151.04M |
| Total Expenses (Quarterly) | 168.97M |
| EPS Diluted (Quarterly) | -0.138 |
| Enterprise Value | 10.04B |
| Gross Profit Margin (Quarterly) | 74.36% |
| Profit Margin (Quarterly) | -11.87% |
| Earnings Yield | -0.77% |
| Normalized Earnings Yield | -0.7811 |